<DOC>
	<DOCNO>NCT00312156</DOCNO>
	<brief_summary>The trial conduct Europe Middle East . The aim trial compare use Insulin Detemir twice daily combine mealtime Insulin Aspart NPH Insulin twice daily combine mealtime Insulin Aspart . The trial involve child adolescent Type 1 Diabetes .</brief_summary>
	<brief_title>Comparison Efficacy Safety Insulin Detemir NPH Insulin Children Adolescents With Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>Type 1 diabetes least 12 month Informed consent obtain BMI : 67 year : less equal 19 kg/m2 , 89 year : less equal 20 kg/m2 , 1011 year : less equal 22 kg/m2 , 1213 year : less equal 24 kg/m2 1417 year : less equal 27 kg/m2 . HbA1c equal less 12.0 % Proliferate retinopathy maculopathy Total daily insulin dose great 2.00 IU/kg Any condition disease rule trial participation accord judgement investigator . Mental incapacity , unwillingness language barrier preclude understanding cooperation . A lifestyle incompatible trial participation</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>